2022 annual financial data
Lexeo Therapeutics 2022 Operating margin
Lexeo Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -9,252.14%.
Operating income was -60,509,000 USD and net income was -59,277,000 USD.
Operating cash flow was -54,560,000 USD.
Get free Lexeo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 654,000 USD
- Operating income
- -60,509,000 USD
- Net income
- -59,277,000 USD
- Operating cash flow
- -54,560,000 USD